Arabic Arabic English English French French German German
dark

Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab

Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Synertech Medical Launches Single-Use Sterile Dural Repair Kit in the US to Improve Operating Room Efficiency

Next Post

St. Luke’s Provides Treatment for COVID ‘Long Haulers’

Related Posts
Total
0
Share